The present invention relates to novel ophthalmic pharmaceutical compositions comprising an inflammation-treating amount of a 4-aminoquinoline compound, derivative, isomers, or chemical salts, and methods for using these compositions for the treatment of ocular inflammatory conditions by topical administration directly to the eye.

 
Web www.patentalert.com

< Single-electron transistor using nanoparticles

< Method and apparatus for continuous particle production using supercritical fluid

> Devices having patterned regions of polycrystalline organic semiconductors, and methods of making the same

> Full color display structures using pseudomorphic cladded quantum dot nanophosphor thin films
~ 00279